ask="N/A"
ask_size="N/A"
average_daily_volume="3913530"
bid="N/A"
bid_size="N/A"
book_value="-0.15"
change="+0.25"
change_from_200_day_moving_average="0.83"
change_from_50_day_moving_average="0.49"
change_from_52_week_high="-0.05"
change_From_52_week_low="1.17"
change_in_percent="+21.19%"
close="1.43"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.46"
ebitda="-30.10M"
eps_estimate_current_year="-0.38"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.27"
ex_dividend_date="N/A"
float_shares="87512000"
high="1.48"
high_52_weeks="1.48"
last_trade_date="3/13/2017"
last_trade_price="1.43"
last_trade_size="6308"
last_trade_time="4:01pm"
low="1.23"
low_52_weeks="0.26"
market_capitalization="142.74M"
moving_average_200_day="0.60"
moving_average_50_day="0.94"
name="Protalix BioTherapeutics
Inc. "
notes="N/A"
one_year_target_price="2.63"
open="1.23"
pe_ratio="3.08"
peg_ratio="-0.11"
percent_change_from_200_day_moving_average="+137.90%"
percent_change_from_50_day_moving_average="+52.17%"
percent_change_from_52_week_high="-3.38%"
percent_change_from_52_week_low="+450.00%"
previous_close="1.18"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="16.55"
revenue="7.12M"
shares_outstanding="99821000"
short_ratio="1.18"
stock_exchange="ASE"
symbol="PLX"
volume="10412089"
weeks_range_52="0.26 - 1.48"
